Exploring the long-term effects of genomic sequencing for newborns
Official title: Long-term Impact and Value of Infant Genomic Sequencing (LIVING)
Funded at Harvard Pilgrim Health Care, INC. · NIH-11176797 · Data updated 2026-11-12
This study is looking at how testing a baby's genes right after birth can help doctors spot any genetic disorders and predict future health issues, so they can provide better care and treatments tailored to each child's needs.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard Pilgrim Health Care, INC. NIH-funded |
| Lab location | 1 site (Canton, UNITED STATES) |
| Project start | September 1, 2024 |
| Project end | May 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $713,919 |
| NIH project number | 5R01HD114807-02 |
| Project ID | NIH-11176797 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include newborns who are undergoing genomic sequencing as part of their initial healthcare assessments.
✕Less likely to help
Patients who are older than newborns or those who do not undergo genomic sequencing may not benefit from this research.
What this research studies
This research investigates how genomic sequencing performed at birth can inform the ongoing healthcare of children. It aims to identify genetic disorders in newborns and assess their predispositions to future diseases, allowing for early interventions that could improve health outcomes. The study will also evaluate how genomic information can guide healthcare providers in managing medications based on genetic factors. By understanding the long-term impacts of genomic sequencing, the research seeks to enhance traditional newborn screening practices.
Why it matters
Potential benefit: If successful, this research could lead to improved health management for newborns, potentially preventing or mitigating future diseases.
How similar studies have gone: Previous research has shown promising results in using genomic sequencing for early disease detection and management, indicating a potential for success in this approach.
Where this research is happening
-
Harvard Pilgrim Health Care, INC.
Canton, United States Active
Researchers
- Principal investigator: Christensen, Kurt Derek — Harvard Pilgrim Health Care, INC.
- Study coordinator: Christensen, Kurt Derek
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.